However, molecular genetic studies have revealed that more than two-thirds of meningiomas carry deletions or mutations in the neurofibromatosis type 2 (NF-2) gene [6], which typically manifest as multiple tumors with a relatively poor prognosis, thus entailing an increased risk of mortality [7,8]. The gene discussed is NF2; the disease is meningioma.